Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests (Revised): Guidance for Test Developers and Food and Drug Administration Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 12, 2023
December 30, 2024
91e43210-583d-46a9-919c-aab24aa0fad0
Related Documents
Certificates of Confidentiality: Guidance for Sponsors, Sponsor-Investigators, Researchers, Industry, and Food and Drug Administration Staff
Guidance DocumentNovember 13, 2020Office of the Commissioner
Policy for Coronavirus Disease-2019 Tests (Revised): Guidance for Developers and Food and Drug Administration Staff
Guidance DocumentJanuary 12, 2023Center for Devices and Radiological Health
Off-The-Shelf Software Use in Medical Devices: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentAugust 11, 2023Center for Devices and Radiological Health
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox